AnteoTech Limited (ASX:ADO)

Market Cap	65.46M
Revenue (ttm)	968.88K
Net Income (ttm)	-6.76M
Shares Out	2.73B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,215,638
Average Volume	1,873,303
Open	0.0220
Previous Close	0.0220
Day's Range	0.0220 - 0.0240
52-Week Range	0.0070 - 0.0367
Beta	0.78
RSI	59.81
Earnings Date	Oct 29, 2025

About AnteoTech

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micr...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Merrill Gray
• Employees: 99
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ADO

Financial Performance

In 2025, AnteoTech's revenue was 968,878, an increase of 110.44% compared to the previous year's 460,397. Losses were -6.76 million, -23.89% less than in 2024.